These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22673318)

  • 1. Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer.
    Abonowara A; Quraishi A; Sapp JL; Alqambar MH; Saric A; O'Connell CM; Rajaraman MM; Hart RD; Imran SA
    Clin Invest Med; 2012 Jun; 35(3):E152-6. PubMed ID: 22673318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
    Biondi B; Cooper DS
    Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
    Do Cao C; Wémeau JL
    Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
    Wang LY; Smith AW; Palmer FL; Tuttle RM; Mahrous A; Nixon IJ; Patel SG; Ganly I; Fagin JA; Boucai L
    Thyroid; 2015 Mar; 25(3):300-7. PubMed ID: 25386760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.
    Sugitani I; Fujimoto Y
    Surgery; 2011 Dec; 150(6):1250-7. PubMed ID: 22136848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum free thyroxine concentration and atrial fibrillation.
    Gammage MD; Parle JV; Holder RL; Roberts LM; Hobbs FD; Wilson S; Sheppard MC; Franklyn JA
    Arch Intern Med; 2007 May; 167(9):928-34. PubMed ID: 17502534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
    Jin S; Yang YT; Bao W; Bai Y; Ai JW; Liu Y; Yong H
    Endocrine; 2019 Aug; 65(2):327-337. PubMed ID: 31056722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer.
    Liu C; Lv H; Li Q; Fu S; Tan J; Wang C; Wang X; Ma Y
    Medicine (Baltimore); 2020 Jul; 99(28):e21190. PubMed ID: 32664162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma.
    Mazziotti G; Formenti AM; Frara S; Olivetti R; Banfi G; Memo M; Maroldi R; Giubbini R; Giustina A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):956-964. PubMed ID: 29121201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
    Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
    Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid stimulating hormone testing in ED evaluation of patients with atrial fibrillation and various psychiatric diagnoses.
    Apostol M; Keeran M; Klempf N; McCoskey V; Ernst AA; Weiss SJ; Sarangarm D
    Am J Emerg Med; 2019 Jun; 37(6):1114-1117. PubMed ID: 30194020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid-hormone therapy and thyroid cancer: a reassessment.
    Biondi B; Filetti S; Schlumberger M
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):32-40. PubMed ID: 16929364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
    Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
    Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.
    Moon JH; Ahn S; Seo J; Han JW; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Kim KW; Jang HC
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3782-9. PubMed ID: 25029415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between thyroid dysfunction and incidence of atrial fibrillation in patients with stable angina pectoris].
    Xu Y; Guo Y; Wang W; Yuan X; Zhang K; Yang M; Yan H; Zhang S; Yang YJ; Tang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):374-8. PubMed ID: 25042913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of iatrogenic hyperthyroidism in elderly patients with atrial fibrillation in an anticoagulation clinic.
    Krishnan SK; Dohrmann ML; Brietzke SA; Fleming DA; Flaker GC
    Mo Med; 2011; 108(4):280-3. PubMed ID: 21905446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer.
    Freudenthal B; Williams GR
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):325-328. PubMed ID: 28043744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.